Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update

/PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc....

May 16, 2026 - 01:00
 0  1
Citius Oncology, Inc. Reports Fiscal Second Quarter 2026 Financial Results and Provides Business Update
/PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc....

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow